[12] [13] A comprehensive 2017 meta-analysis published in Diabetes Care examined data from over 60,000 patients and found no statistically significant increased risk of pancreatitis with GLP-1 agonists versus comparators
15 Potential Additional Benefits Several studies have investigated potential additional benefits of DPP-4 inhibitors, including microvascular and macrovascular effects, effects on blood pressure (BP) and weight, and risk of hypoglycemia
The results showed that cinchonine could reduce hepatic steatosis and protect liver injury
Whether your goals include weight management, metabolic balance, improved vitality, or proactive aging support, Sage is here to guide you with expertise, compassion, and intention
If you see GLP-1 patch ads, please be cautious